Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Recurrence 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Cisplatin 207 Radiotherapy 165 Cetuximab 121 pembrolizumab 99 Fluorouracil 78 Docetaxel 76 Paclitaxel 67 Carboplatin 66 Radiotherapy, Intensity-Modulated 62 Surveys and Questionnaires 38 Nivolumab 38 Radiation 31 Drug Therapy 28 Blood Specimen Collection 24 Gemcitabine 22 Immunohistochemistry 20 Gefitinib 20 Erlotinib Hydrochloride 19 durvalumab 17 Surgical Procedures, Operative 17 Standard of Care 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 Pemetrexed 15 atezolizumab 14 Low-Level Light Therapy 14 Gene Expression Profiling 14 Chemotherapy, Adjuvant 14 Biopsy 14 Bevacizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡